To our knowledge, the only study testing the association between the CYP2C19 genotype and any movement disorder is the study of Alonso‐Navarro et al., [9] which showed a significantly higher frequency of CYP2C19 intermediate metabolizer status in the cohort of patients with essential tremor compared with healthy controls. This evidence concerns the gene CYP2C19 and essential tremor.